Robert Mancini, PharmD, BCOP | Authors

KAISER FOUNDATION HOSPITALS

2200 OFARRELL ST

Articles

Oral Oncolytics: Part 2-Legislation Targeting Cost & Access, and Other Initiatives to Reduce Costs

September 15, 2013

We examine efforts to correct cost inequities of oral anti-cancer agents through legislation, and we look at further efforts to reduce the cost of oral chemotherapy via cycle management and waste reduction.